FINANCIAL CHRONICLE™
Dear Reader,

Registration with the Sri Lanka FINANCIAL CHRONICLE™️ would enable you to enjoy an array of other services such as Member Rankings, User Groups, Own Posts & Profile, Exclusive Research, Live Chat Box etc..

All information contained in this forum is subject to Disclaimer Notice published.


Thank You
FINANCIAL CHRONICLE™️
www.srilankachronicle.com


Join the forum, it's quick and easy

FINANCIAL CHRONICLE™
Dear Reader,

Registration with the Sri Lanka FINANCIAL CHRONICLE™️ would enable you to enjoy an array of other services such as Member Rankings, User Groups, Own Posts & Profile, Exclusive Research, Live Chat Box etc..

All information contained in this forum is subject to Disclaimer Notice published.


Thank You
FINANCIAL CHRONICLE™️
www.srilankachronicle.com
FINANCIAL CHRONICLE™
Would you like to react to this message? Create an account in a few clicks or log in to continue.
FINANCIAL CHRONICLE™

Encyclopedia of Latest news, reviews, discussions and analysis of stock market and investment opportunities in Sri Lanka

LISTED COMPANIES

Submit Post


ADVERTISE
Poll

EXCHANGE RATE PREDICTION: 2022

 
 
 
 

View results

ශ්‍රී ලංකා මූල්‍ය වංශකථාව - සිංහල
Submit Post


CONATCT US


Send your suggestions and comments

* - required fields

Read FINANCIAL CHRONICLE™ Disclaimer



Latest topics

» Hotels controlled by LOLC Group
by Maharaja Today at 1:36 am

» AAIC Next multibugger- destnation beyond EXPO.
by ADVENTUS Yesterday at 10:30 pm

» BIL is still a baby
by Maharaja Yesterday at 12:36 pm

» HOTEL AND TRAVEL SECTOR
by rajini Thu Aug 18, 2022 11:38 pm

» IMF team to visit Sri Lanka by month-end for staff-level agreement - CB Governor
by ADVENTUS Thu Aug 18, 2022 6:32 pm

» LOLC to enter the giant Indian Market
by Chula Thu Aug 18, 2022 6:05 pm

» Stocks on the Radar at CSE
by samaritan Thu Aug 18, 2022 5:28 pm

» SUNSHINE HOLDINGS PLC (SUN.N0000)
by K.R Thu Aug 18, 2022 4:14 pm

» Sri Lanka's first ever fully electric super car 'Vega'
by samaritan Thu Aug 18, 2022 2:19 pm

» SEMB.N and SEMB.X
by adjoseph Thu Aug 18, 2022 1:12 pm

» Forcus on Government controlled entities
by D.G.Dayaratne Thu Aug 18, 2022 9:26 am

» ACL; MELS; HHL; BIL; LWL- STOCKS TO WATCH
by ADVENTUS Wed Aug 17, 2022 10:33 pm

» BAIRAHA FARMS PLC (BFL.N0000)
by arun.cse Wed Aug 17, 2022 4:37 pm

» LIOC ....Get in soon
by arun.cse Wed Aug 17, 2022 3:55 pm

» RENUKA AGRI FOODS PLC (RAL.N0000) TP. 7
by Cma Wed Aug 17, 2022 2:08 am

» Sri Lankan Port Transshipment Hub Threats & Opportunities
by rajini Wed Aug 17, 2022 12:53 am

» LANKA INDIAN OIL CORPORATION - Maharaja
by Maharaja Tue Aug 16, 2022 11:07 pm

» AAIC 100 = SCAP 16
by SamJay1974 Tue Aug 16, 2022 8:12 pm

» APLA - Very very undervalued share - Target Price
by Jana Tue Aug 16, 2022 7:07 pm

» HAYLEYS PLC (HAYL.N0000)
by Chamath1980 Tue Aug 16, 2022 5:07 pm

EXPERT CHRONICLE™

MARKET CHAT


CHRONICLE™ ANALYTICS


ECONOMIC CHRONICLE

GROSS DOMESTIC PRODUCT (GDP)


CHRONICLE™ YouTube

LATEST TWEETS

You are not connected. Please login or register

FINANCIAL CHRONICLE™ » EXPERT CHRONICLE™ » Global COVID cases rise as BA.4 and BA.5 expand

Global COVID cases rise as BA.4 and BA.5 expand

Go down  Message [Page 1 of 1]

samaritan

avatar
Moderator
Moderator

Global COVID cases rise as BA.4 and BA.5 expand Covid_testing_in_puerto_rico-natl_guard

COVID-19 cases jumped 18% last week and are at their highest levels since April, and the increase comes as the more transmissible Omicron BA.4 and BA.5 subvariants cause most infections, the World Health Organization (WHO) said today in its latest update.

BA.4, BA.5 make up 55% of global samples

Four of the six WHO regions saw rises last week: the Eastern Mediterranean, Europe, Southeast Asia, and the Americas. Globally, deaths stayed level, but were up in the Eastern Mediterranean, Southeast Asian, and Americas regions.
About 4.1 million cases were reported to the WHO last week, likely an undercount given reduced testing in many countries. The United States, Germany, Brazil, Italy, and China reported the most cases.
At a briefing today of the WHO's Pan American Health Organization (PAHO), officials said cases rose in all four subregions in the Americas, with a jump of 24.6% in South America. Cases in North America rose 7.7% last week, mainly due to rises in the United States and Mexico.
The WHO said BA.4 and BA.5 subvariants continue to make up an increasing proportion of sequenced samples. Both share a mutation linked to greater transmissibility, and early indications suggest that evolutionary changes increase immune escape following infection or vaccination.
Combined, BA.4 and BA.5 made up 55% of sequenced samples. For the week ending Jun 19, BA.5 represented 43% of samples, up from 28% the week before. And BA.4 represented 12% of sequenced samples, up from 9% the previous week.

Pandemic changing 'but it's not over'

At a WHO briefing today, Director-General Tedros Adhanom Ghebreyesus, PhD, said cases are rising in 110 countries, fueled by BA.4 and BA.5 in many countries. "This pandemic is changing but it's not over. We have made progress, but it's not over." He reiterated his concerns about reduced testing and genetic sequencing, which reduces the world's ability to track outbreak and virus changes.
Taking stock of the world's vaccination status, Tedros said only 58 countries have reached the mid-year target of vaccinating at least 70% of their population, with the average rate in low-income countries at 13%. He urged countries to vaccinate 100% of their health workers and people over 60 as soon as possible, noting that 75% of the group is now vaccinated.
For the general population, Tedros said it's important to keep strengthening immunity, which helps reduce severity and longer-term impacts from the disease. "Even relatively 'mild' cases are disruptive and damaging, keeping children out of school and adults from work, which causes further economic and supply chain disruption," he said.

Critical need for next-generation vaccines

Tedros said though it makes sense to update vaccines to cover evolving variants, the pace of mutation means the world continues to play catch-up. Second-generation vaccines that stop or reduce infection would be a major step forward, but ideally, the solution is a pan-coronavirus vaccine that covers current and future variants, he said.
In a related development, BioNTech said today that it and Pfizer would begin human trials of a pan-coronavirus vaccine in the second half of the year, according to Reuters, which cited slides from the company's investor day.

US booster uptake lags

Booster uptake is lukewarm in some US age-groups, according to an ABC News report that looked at federal data. Less than 10% of eligible children ages 5 to 11 have received a booster dose, and just 28.7% of adolescents ages 12 to 17 have gotten an extra dose. And less than 40% of eligible adults ages 18 to 49 have received a third dose.
The 7-day average for new daily cases is 113,849, with daily deaths averaging 385, according to the Washington Post tracker. Cases are up 21% in the past week, with deaths up by 41% and hospitalizations rising by 8%.
In other US developments, Eli Lilly said today that it would supply an additional 150,000 doses of bebtelovimab, a monoclonal antibody treatment under emergency use authorization for the treatment of mild-to-moderate COVID-19 infections in people ages 12 and older.
The drug continues to show neutralization activity against emerging Omicron variants, including BA.4 and BA.5. The purchase is worth $275 million and is expected to meet demand through late August.

https://www.cidrap.umn.edu/news-perspective/2022/06/global-covid-cases-rise-ba4-and-ba5-expand

Share this post on: redditgoogle

No Comment.

Back to top  Message [Page 1 of 1]

Permissions in this forum:
You cannot reply to topics in this forum